✦ LIBER ✦

Is High-Dose Chemotherapy After Primary Chemotherapy a Therapeutic Option for Patients With Primary Mediastinal Nonseminomatous Germ Cell Tumor?

✍ Scribed by Giuseppe Luigi Banna; Ugo De Giorgi; Benvenuto Ferrari; Luca Castagna; Marco Alloisio; Maurizio Marangolo; Giovanni Rosti; Armando Santoro

Book ID: 116279054
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 117 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.06.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line sequential high-dose VIP chem

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial

✍ Bokemeyer, C; Schleucher, N; Metzner, B; Thomas, M; Rick, O; Schmoll, H-J; Kollm 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Salvage therapy with high-dose chemother

Salvage therapy with high-dose chemotherapy and autologous bone marrow support in the treatment of primary nonseminomatous mediastinal germ cell tumors

✍ E. R. Broun; C. R. Nichols; L. H. Einhorn; G. J. K. Tricot 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 2 views

Analysis of salvage treatments for germ

Analysis of salvage treatments for germ cell cancer patients who have relapsed after primary high-dose chemotherapy plus autologous stem cell support

✍ C. Kollmannsberger; N. Schleucher; O. Rick; B. Metzner; J.T. Hartmann; P. Schöff 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Treatment of primary mediastinal large B

Treatment of primary mediastinal large B cell lymphoma with an alternating chemotherapy regimen based on high-dose methotrexate

✍ T. Fietz; W. U. Knauf; M. Hänel; A. Franke; M. Freund; E. Thiel; for the East Ge 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 177 KB

High-dose chemotherapy and autologous bo

High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

✍ Robert J. Motzer; Subhash C. Gulati; John P. Crown; Steven Weisen; Maryanne Dohe 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 682 KB

Risk factors in germ cell tumour patient

Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: Evaluation of a prognostic score for survival after high-dose chemotherapy

✍ C. Sammler; J. Beyer; C. Bokemeyer; J.T. Hartmann; O. Rick 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 265 KB